November 13, 20190Comments

Earnings Distortion Alert: This Pharmacy Giant Has Understated Earnings

Our Earnings Distortion Scorecard reveals this stock has significantly understated earnings and investors should look to buy this stock ahead of its earnings report.

by Kyle Guske II

November 12, 20190Comments

Focus List Stocks: Long – Update 11/12/19

We’ve added the following stock to our Focus List – Long Model Portfolio as of November 12, 2019.

by Kyle Guske II

November 12, 20190Comments

Position Close Update: Texas Instruments (TXN)

This stock no longer presents the same risk/reward and was recently downgraded to an Unattractive rating.

by Kyle Guske II

November 11, 20190Comments

Earnings Distortion Scorecard Reveals Another Stock to Avoid

Overstated earnings, combined with its expensive valuation, make this stock more likely to miss earnings expectations in the short-term and underperform the market in the long-term.

by Kyle Guske II

November 11, 20190Comments

Podcast: Why An Industrials Giant Is in the Danger Zone

Investment Analyst Kyle Guske II sat down with Chuck Jaffe of Money Life to talk about our Danger Zone pick this week: Earnings Distortion Scorecard Reveals Another Stock to Avoid.

by Kyle Guske II

November 11, 20190Comments

FASB Tracking & Alerts: What Investors Need to Know: 4Q19

Cut through the noise and get clear insights into what matters when it comes to accounting rule changes.

by Kyle Guske II

November 8, 20190Comments

ICYMI: New Version of HBS & MIT Sloan Paper Proves Manager Bias, New Long Idea, Benzinga Interview, Leverage the Earnings Distortion Scorecard & Stock Picking Accolades

Here's what happened at New Constructs this past week.

by Kyle Guske II

November 8, 20190Comments

November 2019 Stock Picking Accolades: #3 in Healthcare, #3 in Consumer Staples, #3 Large-Cap & More

We are November’s #3 ranked stock picker in Large-Cap, #3 in Consumer Staples, #3 in Healthcare, #5 in Industrials, and #10 LTM.

by Kyle Guske II

November 7, 20190Comments

See How Our Data Helps You Pick Better Stocks on Benzinga’s PreMarket Prep

We joined Benzinga’s PreMarket Prep on November 7 to discuss the HBS & MIT Sloan paper, its takeaways, and how you can use our data featured in the paper to pick better stocks.

by Kyle Guske II

November 6, 20190Comments

Featured Stock in October’s Dividend Growth Model Portfolio

Six new stocks made our Dividend Growth Stocks Model Portfolio this month. Get a free look at one of the stocks in the most recent portfolio.

by Kyle Guske II

November 6, 20190Comments

Most Attractive Stocks Model Portfolio: November 2019

Gold Members and higher can access November's 40 Most Attractive Stocks as of Wednesday, November 6.

by Kyle Guske II

November 6, 20190Comments

Most Dangerous Stocks Model Portfolio: November 2019

Gold Members and higher can access November's 40 Most Dangerous Stocks as of Wednesday, November 6.

by Kyle Guske II

November 4, 20190Comments

Podcast: Why This Industrials Firm Is in the Danger Zone

Investment Analyst Sam McBride sat down with Chuck Jaffe of Money Life to talk about our Danger Zone pick this week: Earnings Distortions Make This Stock a Sell.

by Kyle Guske II

November 4, 20190Comments

Model Portfolio Performance Through 3Q19

Our model portfolios offer clients multiple strategies to outperform in good and bad markets. See the performance of these model portfolios through 3Q19.

by Kyle Guske II

November 1, 20190Comments

ICYMI: HBS & MIT Sloan Paper Features Our “Novel Dataset”, Using Earnings Distortion to Pick Stocks, TDA Network Interview, Impact of an Accounting Rule & Model Portfolio Updates

Here's what happened at New Constructs this past week.

by Kyle Guske II

November 1, 20190Comments

Special Offer: Focus List Stocks: Short Model Portfolio for only $14.99

Just this month, we’re giving you the most recent Focus List Stocks: Short Model Portfolio for only $14.99.

by Kyle Guske II

November 1, 20190Comments

We Discuss EPS Distortion and Picking Stocks on TD Ameritrade Network

We joined TDA Network’s Morning Trade Live on Friday, November 1 to provide insights into Earnings Distortion for companies in the S&P 500, especially AbbVie (ABBV).

by Kyle Guske II

October 31, 20190Comments

Featured Stock in October’s Safest Dividend Yields Model Portfolio

Five new stocks made our Safest Dividend Yields Model Portfolio this month. Get a free look at one of the stocks in this month’s portfolio.

by Kyle Guske II

October 30, 20190Comments

Earnings Distortion Makes This Stock A Buy

Understated earnings and cheap valuation give this company a higher chance of beating earnings in the short-term and outperforming the market in the long-term.

by Kyle Guske II

October 30, 20190Comments

How To Avoid the Worst Style Mutual Funds 4Q19

The large number of mutual funds has little to do with serving investors’ best interests. Here are three red flags investors can use to avoid the worst mutual funds.

by Kyle Guske II

« Older Articles